Under the terms of the Samsung Agreement, the Company is obligated to make specified minimum purchases of leronlimab from Samsung pursuant to forecasted requirements which the Company will provide to Samsung. The first forecast will be delivered to Samsung by March 31, 2020.
From the looks of it and lack of NP to say so, I don't think CYDY has made a minimum purchase of leronlimab via a forecast that was to be delivered by the deadline of March 31, 2020.
If a minimum purchase was made pretty sure NP would have bragged about it a week ago.